Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02999633
Title Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications

T-cell adult acute lymphocytic leukemia

childhood T-cell acute lymphoblastic leukemia

Therapies

Isatuximab

Age Groups: child | senior | adult
Covered Countries USA | ITA | FRA

Facility Status City State Zip Country Details
Investigational Site Number 8400002 Atlanta Georgia 30342 United States Details
Investigational Site Number 8400003 Hackensack New Jersey 07601 United States Details
Investigational Site Number 8400001 Houston Texas 77030 United States Details
Investigational Site Number 2460001 Helsinki 00029 Finland Details
Investigational Site Number 2500005 Nantes Cedex 01 44093 France Details
Investigational Site Number 2500001 Paris Cedex 10 75475 France Details
Investigational Site Number 2500004 Pessac 33600 France Details
Investigational Site Number 2500002 Pierre Benite 69310 France Details
Investigational Site Number 3480001 Budapest 1083 Hungary Details
Investigational Site Number 3480003 Budapest 1097 Hungary Details
Investigational Site Number 3480002 Debrecen 4032 Hungary Details
Investigational Site Number 3800001 Bergamo 24127 Italy Details
Investigational Site Number 3800004 Brescia 25123 Italy Details
Investigational Site Number 4400001 Vilnius 08661 Lithuania Details
Investigational Site Number 6430003 Moscow 117198 Russian Federation Details
Investigational Site Number 6430004 Moscow 125167 Russian Federation Details
Investigational Site Number 6430001 Moscow 129301 Russian Federation Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field